https://www.avient.com/sites/default/files/2022-08/ColorMatrix Excelite Product Bulletin.pdf
Through accurate
and consistent metering, Excelite additives enable
greater control of production tolerances and improve
linear consistency.
This process allows
greater control over production tolerances, thus reducing scrap rates, improving quality, and optimizing
process capacity.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication
of performance or properties obtained or obtainable on larger-scale equipment.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives_Laser Welding Additives for Medical Devices Application Bulletin.pdf
Avient uses a “systems approach” to develop the
laser welding solution most adapted to your project,
taking into consideration the following aspects:
• Transmitting and absorbing parts
• Polymer type and grade
• Dispersion of the additive in the final part
• Sufficient and consistent loading of the additive
• Part design: attention to flow separation at the
welding interface
• Color and opacitiy
• Quality control – e.g. establish suitable control
parameters (UV Visible Spectra)
• Laser wavelength and processing parameter
Mevopur™ Healthcare Functional Additives
formulated for laser welding are designed for use
in healthcare applications.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication
of performance or properties obtained or obtainable on larger-scale equipment.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
https://www.avient.com/sites/default/files/2025-04/Supplier Code of Conduct FV_Eng.pdf
Activities
that have the potential to adversely impact human
health or the environment shall be appropriately
managed, measured, controlled, and handled prior
to release of any substance into the environment
Comply with all applicable import and export
controls, as well as trade compliance and antitrust
laws
Inform Avient of financial, economic, supply changes
(including origin or conflict status of 3TG metals),
government regulations or other materials
conditions that could affect ongoing operations or
operating decisions, or if the company has been
debarred as a government contractor
https://www.avient.com/sites/default/files/2023-06/Supplier Code of Conduct FV.pdf
Activities
that have the potential to adversely impact human
health or the environment shall be appropriately
managed, measured, controlled, and handled prior
to release of any substance into the environment
Comply with all applicable import and export
controls, as well as trade compliance and antitrust
laws
Inform Avient of financial, economic, supply changes
(including origin or conflict status of 3TG metals),
government regulations or other materials
conditions that could affect ongoing operations or
operating decisions, or if the company has been
debarred as a government contractor
https://www.avient.com/sites/default/files/2021-10/information-systems-use-policy-final-9.1.2021.pdf
http://polynet/ethics/Portals/23/documents/Cyber%20and%20Data%20Incident%20Response%20Policy/Cyber_Incident_Response_Policy-September%202018_EN%20-%20v1.pdf
http://polynet/ethics/Portals/23/documents/Cyber%20and%20Data%20Incident%20Response%20Policy/Cyber_Incident_Response_Policy-September%202018_EN%20-%20v1.pdf
Confidential 6 Avient IT Department
Information Systems Use Policy September 1, 2021
APPENDIX A: DEFINITIONS
In addition to those terms defined within the body of this Policy, the following definitions are
used:
“Avient Data” – includes (a) all data and information generated, stored, collected, or processed by Avient
through Information Systems; (b) all information under the control of Avient and originating from,
belonging to, or received from customers, suppliers, or third parties; (c) all data and information regarding
intellectual property of Avient; and (d) purely intra-Avient information connected to individual employees,
such as Information System usernames, passwords, and company ID.
For example, Personal Data could be an individual’s Social Security Number (SSN), name,
address, date of birth, tax identification number or equivalent, credit or debit card number, or financial
account number.
Information Systems” – any software, hardware, firmware, data networks, physical or remote storage
media, or other digital services used, owned, accessed, controlled, leased, or operated by Avient.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
Use Targets
What is the targeted reduction in use of the toxic substance at the facility?
No quantity
Quantity Unit
or
What is the targeted timeframe for this reduction?
No quantity
Quantity Unit
or
What is the targeted timeframe for this reduction?
https://www.avient.com/sites/default/files/resources/IR_Deck_11.4.19.pdf
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
• This presentation includes the use of both GAAP (generally accepted
accounting principles) and non-GAAP financial measures.
The non-GAAP
financial measures include: adjusted EPS, adjusted operating income, and
return on invested capital
A reconciliation of each non-GAAP financial measure with the most
directly comparable GAAP financial measure is attached to this
presentation which is posted on our website at www.polyone.com.
https://www.avient.com/sites/default/files/resources/11.30.18%2520Investor%2520Presentation%2520V1.pdf
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
• This presentation includes the use of both GAAP (generally accepted
accounting principles) and non-GAAP financial measures.
The non-GAAP
financial measures include: adjusted EPS, adjusted operating income, and
return on invested capital
A reconciliation of each non-GAAP financial measure with the most
directly comparable GAAP financial measure is attached to this
presentation which is posted on our website at www.polyone.com.
https://www.avient.com/sites/default/files/2025-04/Corporate Governance Guidelines. March 2025 - Final and Approved version.pdf
The following relationships will not be considered to be material relationships that would
impair a director’s independence:
(i) If the director is, or has an immediate family member who is, a partner (general or
limited) in, or a controlling stockholder, equity holder, executive officer, other
employee, or director of, any organization to which the Company made, or from
which the Company received, payments for property or services in the current or any
of the past three fiscal years where the amount involved in such transaction in any
such fiscal year was less than the greater of $1 million or 2% of the organization’s
consolidated gross revenues for that year;
(ii) If the director is, or has an immediate family member who is, a director or trustee of
any organization to which the Company has made, or from which the Company has
received payments for property or services, and the director (or his/her immediate
family member) was not involved in the negotiations of the terms of the transaction,
did not, to the extent applicable, provide any services directly to the Company, and
did not receive any special benefits as a result of the transaction; or
(iii) If the director, or an immediate family member of the director, serves as an officer,
director or trustee of a foundation, university, charitable or other not-for-profit
organization, and the Company’s discretionary charitable contributions to the
organization, in the aggregate are less than the greater of $1 million or 2% of that
organization’s latest publicly available annual consolidated gross revenues.
The Board administers its risk oversight function directly and through its committees.
8
The Board has delegated specific risk oversight responsibility to the committees of the
Board as follows: (i) the Audit Committee oversees risks related to the Company’s
financial statements, financial reporting processes, internal controls, information
technology, and cybersecurity; (ii) the Compensation Committee oversees risks related to
the Company’s compensation programs; (iii) the Governance and Corporate
Responsibility Committee oversees risks related to the Company’s programs, policies,
and practices related to certain sustainability and governance matters, including a review
of reports on corporate responsibility and/or sustainability published by the Company;
and (iv) the Environmental, Health and Safety Committee oversees risks related to safety,
health, physical security, environmental, and product stewardship matters.
The Board and its Committees may, in appropriate circumstances
9
and at Company expense, consult and retain independent legal, financial or other
advisors.
4.
https://www.avient.com/products/polymer-additives/barrier-and-scavenger-additives
ColorMatrix™ AAzure™ Acetaldehyde Control Technology for PET
ColorMatrix™ AAzure™ Acetaldehyde Control Technology for PET
ColorMatrix™ AAzure™ Acetaldehyde Control Technology for PET